GTAM
Global Trust Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.15K | Hold |
50
| – | – | ﹤0.01% | 418 |
|
|
2025
Q1 | $4.06K | Hold |
50
| – | – | ﹤0.01% | 405 |
|
|
2024
Q4 | $4.5K | Hold |
50
| – | – | ﹤0.01% | 448 |
|
|
2024
Q3 | $4.94K | Sell |
50
-100
| -67% | -$9.88K | ﹤0.01% | 415 |
|
|
2024
Q2 | $13.9K | Hold |
150
| – | – | 0.01% | 343 |
|
|
2024
Q1 | $14.2K | Hold |
150
| – | – | 0.01% | 338 |
|
|
2023
Q4 | $13.4K | Buy |
150
+100
| +200% | +$8.93K | 0.01% | 325 |
|
|
2023
Q3 | $3.65K | Hold |
50
| – | – | ﹤0.01% | 374 |
|
|
2023
Q2 | $4.16K | Hold |
50
| – | – | ﹤0.01% | 373 |
|
|
2023
Q1 | $3.81K | Hold |
50
| – | – | ﹤0.01% | 358 |
|
|
2022
Q4 | $4.15K | Hold |
50
| – | – | ﹤0.01% | 343 |
|
|
2022
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 375 |
|
|
2022
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 367 |
|
|
2022
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 407 |
|
|
2021
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 362 |
|
|
2021
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 341 |
|
|
2021
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 343 |
|
|
2021
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 310 |
|
|
2020
Q4 | $7K | Sell |
50
-50
| -50% | -$7K | ﹤0.01% | 317 |
|
|
2020
Q3 | $11K | Hold |
100
| – | – | 0.01% | 262 |
|
|
2020
Q2 | $11K | Buy |
100
+50
| +100% | +$5.5K | 0.01% | 239 |
|
|
2020
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 292 |
|
|
2019
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 318 |
|
|
2019
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 298 |
|
|
2019
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 339 |
|
|
2019
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 301 |
|
|
2018
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 323 |
|
|
2018
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 345 |
|
|
2018
Q2 | $5K | Hold |
50
| – | – | ﹤0.01% | 339 |
|
|
2018
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 334 |
|
|
2017
Q4 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 354 |
|